repeat
administr
mercuri
brown
norway
bn
rat
induc
product
autoantibodi
laminin
autoantigen
accompani
renal
deposit
immunoglobulin
membran
glomerulonephropathi
graftversushostlik
gvhl
syndrom
character
widespread
necrot
leukocytoclast
vascul
bowel
skin
tissu
also
observ
mercuri
treatment
bn
rat
find
suggest
autoimmun
caus
administr
mercuri
bn
rat
may
result
xenobioticinduc
gvhl
effect
control
lymphocyt
howev
previou
studi
mercuryinduc
autoimmun
never
report
evid
gvhl
lesion
therefor
care
examin
variou
tissu
larg
group
bn
rat
inject
hgcl
identifi
possibl
area
inflammatori
reaction
may
unnot
previou
investig
addit
determin
flow
cytometri
whether
exposur
mercuri
result
percentag
numer
alter
lymphocyt
subpopul
lymphoid
organ
hgcl
treat
bn
rat
present
articl
confirm
mercuri
induc
autoimmun
respons
laminin
corrobor
hypothesi
gvhl
syndrom
regul
lymphocyt
first
chang
cell
treatment
hgcl
infrequ
signific
correl
kinet
autoimmun
respons
laminin
second
detect
gvhl
lesion
skin
intestin
mercurytr
bn
rat
repeat
administr
low
dose
mercuri
brown
norway
bn
rat
induc
product
autoantibodi
laminin
autoantigen
accompani
renal
deposit
immunoglobulin
nephrot
syndrom
review
graftversushostlik
gvhl
syndrom
also
observ
mercuri
treatment
bn
rat
syndrom
character
widespread
necrot
leukocytoclast
vascul
bowel
skin
tissu
exacerb
vivo
administr
monoclon
antibodi
mab
mab
react
isoform
thelper
lymphocyt
compris
high
low
cell
lymphocyt
b
cell
find
suggest
mercuryinduc
autoimmun
bn
rat
may
repres
gvhl
syndrom
driven
increas
type
cytokin
produc
low
cell
howev
previou
studi
mercuryinduc
autoimmun
never
report
evid
gvhl
patholog
earli
public
druet
group
care
describ
presenc
extraren
immun
deposit
detect
major
patholog
lesion
light
microscopi
similarli
earlier
investig
mercuryinduc
autoimmun
never
observ
macroscop
microscop
evid
gvhl
injuri
present
studi
care
examin
variou
tissu
larg
group
bn
rat
inject
hgcl
identifi
possibl
area
inflammatori
reaction
may
miss
previou
investig
addit
perform
flow
cytometri
fcm
analysi
determin
whether
exposur
mercuri
result
percentag
numer
alter
lymphocyt
subpopul
lymphoid
organ
hgcl
treat
bn
rat
present
articl
confirm
mercuri
induc
autoimmun
respons
laminin
corrobor
hypothesi
gvhl
syndrom
regul
cell
first
chang
cell
rare
signific
correl
kinet
hgcl
induc
autoimmun
respons
laminin
second
detect
gvhl
lesion
skin
intestin
mercurytr
bn
rat
total
bn
rat
femal
male
divid
group
differ
age
bodi
weight
rang
g
obtain
two
commerci
sourc
harlan
spraguedawley
indianapoli
charl
river
laboratori
wilmington
anim
hous
plastic
microisol
cage
wood
shave
autom
light
cycl
environ
h
receiv
standard
autoclav
rat
chow
steril
water
ad
libitum
rat
certifi
vendor
free
sendai
viru
pneumonia
viru
mice
sialodacryoaden
viru
rat
corona
viru
kilham
rat
viru
toolan
viru
mous
polioviru
mycoplasma
pulmoni
lymphocyt
choriomening
viru
mous
adenoviru
hantaan
viru
cuniculi
pinworm
rat
hous
viralantibodyfre
facil
monthli
test
sentinel
rat
use
assur
absenc
infect
experiment
anim
rat
maintain
accord
guidelin
institut
anim
care
use
committe
iacuc
univers
massachusett
medic
school
univers
connecticut
health
center
recommend
guid
care
use
laboratori
anim
institut
laboratori
anim
resourc
nation
research
council
nation
academi
scienc
rat
anesthes
prior
treatment
inject
everi
day
subcutan
sc
intraperiton
ip
ml
mercur
chlorid
solut
hgcl
mgml
per
g
bodi
wt
previous
describ
rat
sacrif
differ
interv
treatment
follow
day
one
two
inject
total
dose
g
hgcl
g
bodi
wtrat
day
three
inject
total
dose
g
day
four
inject
total
dose
g
day
five
inject
total
dose
g
day
six
inject
total
dose
g
control
rat
age
weight
inject
hgcl
inject
sc
distil
water
ph
follow
schedul
circul
autoantibodi
laminin
detect
elisa
previous
describ
brief
sera
mercurytr
water
treat
bn
rat
incub
elisa
plate
previous
coat
mous
laminin
lwell
obtain
courtesi
dr
hinda
kleinman
nih
nidr
sera
test
duplic
well
use
dilut
min
incub
wash
horseradish
peroxidaseconjug
affinitypurifi
f
fragment
goat
antibodi
rat
igg
h
l
chain
jackson
immunoresearch
laboratori
inc
west
grove
pa
use
detect
bind
rat
antibodi
laminin
abt
substrat
ad
elisa
plate
read
od
thermomax
elisa
reader
molecular
devic
corpor
menlo
park
ca
interv
min
incub
substrat
room
temperatur
positiveneg
cutoff
line
determin
previous
describ
calcul
mean
od
sd
refer
sera
neg
refer
sera
obtain
bn
rat
start
mercuri
treatment
watertr
rat
posit
control
sera
antibodi
laminin
obtain
mercurytr
bn
rat
examin
previou
studi
spleen
lymph
node
thymu
cell
suspens
obtain
gentli
press
tissu
stainless
steel
screen
mesh
previous
describ
six
proxim
cervic
lymph
node
recov
total
cell
count
subset
analysi
experi
cell
wash
two
chang
cold
medium
rpmi
cell
viabil
determin
trypan
blue
exclus
follow
mous
monoclon
antibodi
mab
rat
cell
surfac
marker
use
antit
antib
cell
rat
mab
use
detect
cell
differ
unconjug
biotinyl
fluorochromeconjug
mab
use
one
twoor
threecolor
immunofluoresc
nonspecif
antibodi
bind
determin
use
appropri
combin
isotypematch
irrelev
mab
secondari
reagent
onecolor
cell
suspens
usual
stain
direct
mab
rat
cell
surfac
marker
etc
conjug
either
fluorescein
isothiocyan
fitc
phycoerythryn
pe
altern
indirect
perform
unlabel
mab
develop
f
fragment
fitcconjug
goat
antimous
igg
antibodi
absorb
affin
chromatographi
rat
igg
column
remov
crossreact
antibodi
stain
cell
done
direct
rat
mab
conjug
fluorescein
isothiocyan
fitc
phycoerythryn
pe
control
routin
includ
fitc
conjug
alon
irrelev
rat
mous
monoclon
antibodi
twocolor
differ
combin
mab
conjug
fitc
biotinyl
mab
plu
pelabel
streptavidin
sa
use
viabil
studi
sampl
unfix
cell
examin
trypan
blue
propidium
iodid
otherwis
cell
suspens
fix
stain
fcm
use
emgrad
paraformaldehyd
solut
pb
fcm
analysi
perform
use
bd
facscan
equip
argonion
laser
light
sourc
cellquest
softwar
dead
cell
contamin
red
blood
cell
exclud
analysi
electron
gate
total
nucleat
cell
analyz
rel
fluoresc
intens
monoclon
antibodi
use
studi
previous
describ
commerci
avail
except
rat
mab
obtain
hybridoma
cultur
laboratori
demonstr
rat
immunoglobulin
g
igg
bound
rat
tissu
perform
direct
immunofluoresc
dif
previous
describ
cryostat
section
rat
kidney
intestin
skin
thyroid
liver
parotid
pancrea
lung
etc
stain
fitcconjug
rabbit
antibodi
rat
igg
jackson
immunoresearch
laboratori
inc
read
use
fluoresc
microscop
equip
epiillumin
leitz
dialux
e
leitz
inc
rockleigh
nj
duplic
section
rat
examin
defin
posit
linear
stain
igg
present
level
basement
membran
intens
dif
stain
section
subject
grade
scale
neg
highli
posit
section
grade
higher
consid
posit
sampl
kidney
thyroid
pancrea
intestin
skin
liver
parotid
lung
etc
mercurytr
control
bn
rat
fix
buffer
formalin
embed
paraffin
section
stain
h
e
separ
sampl
tissu
embed
plastic
medium
polysci
inc
warrington
pa
section
cut
sorval
microtom
dupont
instrument
newtown
ct
section
stain
toluidin
blue
duplic
section
h
e
diffquik
american
scientif
product
section
examin
light
microscopi
elisa
dif
test
perform
duplic
data
obtain
experiment
control
group
express
mean
standard
error
mean
sem
fcm
analysi
perform
singl
sampl
rat
data
group
present
mean
sem
histopatholog
immunohistopatholog
elisa
fcm
result
statist
evalu
oneway
analysi
varianc
anova
follow
post
hoc
mean
test
fisher
protect
least
signific
differ
scheff
gameshowel
dunnett
multipl
comparison
procedur
statview
program
macintosh
comput
abacu
concept
inc
berkeley
ca
use
purpos
sera
total
bn
rat
treat
hgcl
test
elisa
antibodi
laminin
none
rat
sacrif
day
treatment
therefor
receiv
total
g
hgcl
g
bodi
wtrat
develop
antibodi
laminin
tabl
hand
posit
reaction
obtain
sera
rat
sacrif
day
sacrif
day
sera
obtain
day
treatment
rat
day
day
day
found
posit
antibodi
laminin
shown
tabl
increas
percentag
posit
anim
correl
time
treatment
total
amount
mercuri
receiv
rat
serum
level
antibodi
laminin
also
increas
time
indic
mean
elisa
od
data
shown
sera
total
control
bn
rat
inject
water
ph
mercuri
solut
sacrif
differ
time
day
day
day
contain
antibodi
laminin
experi
perform
onecolor
twocolor
detect
kinet
possibl
chang
lymphocyt
subpopul
obtain
six
proxim
cervic
lymph
node
bn
rat
treat
mercuri
sacrif
differ
time
treatment
tabl
provid
relev
fcm
data
cell
express
andor
tcr
result
fcm
surfac
marker
etc
provid
addit
inform
compar
previous
publish
data
shown
sake
breviti
previous
report
decreas
percentag
lymphocyt
p
p
percentag
singl
posit
cell
bn
rat
inject
hgcl
similar
watertr
control
p
p
p
slightli
decreas
p
vs
control
p
vs
p
vs
p
vs
percentag
lymphocyt
doubl
posit
increas
p
vs
control
unchang
p
slightli
increas
p
decreas
slightli
p
variat
singl
posit
cell
signific
except
day
decreas
p
vs
control
thu
chang
lymphocyt
cell
occur
consist
mercuri
treatment
present
signific
correl
kinet
autoimmun
respons
laminin
evalu
fcm
whether
lymphocyt
subset
exhibit
chang
initi
stage
exposur
mercuri
shown
tabl
four
bn
rat
inject
time
total
g
bw
sacrif
treatment
experienc
modest
increas
total
number
cervic
lymph
node
cell
compar
four
h
otreat
control
group
also
modest
reduct
cell
similar
chang
describ
tabl
less
signific
decreas
previous
observ
group
younger
mercurytr
bn
rat
higher
level
cell
usual
detect
older
rat
also
variat
percentag
cell
test
elisa
sera
four
bn
rat
contain
autoantibodi
laminin
direct
kidney
show
immunoglobulin
bind
renal
structur
thu
time
subset
lymphocyt
includ
cell
data
shown
appear
unaffect
detect
autoimmun
respons
laminin
signific
increas
percentag
absolut
number
nk
cell
nk
lymphocyt
deposit
observ
rat
sacrif
day
first
observ
bn
rat
day
treatment
percentag
posit
anim
increas
anim
sacrif
day
day
day
day
day
control
bn
rat
inject
water
tissuebound
immunoglobulin
deposit
previous
describ
posit
rat
immunoglobulin
bound
kidney
linear
distribut
renal
glomerular
basement
membran
often
tubular
basement
membran
addit
tissu
examin
skin
intestin
liver
parotid
lung
thyroid
pancrea
tongu
esophagu
stomach
heart
uteru
ovari
adren
testi
va
deferen
linear
immunoglobulin
deposit
basement
membran
level
tabl
macroscop
alter
skin
tissu
particular
skin
mercurytr
bn
rat
show
ulcer
surfac
epithelium
similarli
macroscop
appear
intestin
cecal
serosa
mucosa
normal
lumen
intestin
edemat
lack
petechi
sever
hemorrhag
lesion
screen
variou
organ
tissu
possibl
evid
gvhl
histopatholog
induc
mercuri
exposur
tabl
addit
h
estain
section
examin
thick
glycolmethacrylateembed
section
provid
high
resolut
tissu
structur
accur
visual
histopatholog
paraffinembed
section
skin
mercuryinject
bn
rat
show
polymorphonuclear
mononuclear
cell
inflamm
group
rat
compris
anim
receiv
full
mercuri
treatment
total
dose
g
bodi
wtrat
rat
inject
total
g
bodi
wtrat
rat
inject
total
g
bodi
wtrat
also
examin
intestin
group
rat
plu
addit
anim
receiv
total
dose
g
bodi
wt
found
normal
sign
earli
vascul
day
late
vascul
day
mercuri
treatment
detect
leukocyt
infiltr
lamina
propria
mucosa
serosa
duodenum
necrot
vascul
submucos
vessel
colon
mononuclear
cell
infiltr
close
vessel
thu
two
major
target
organ
graftversushost
diseas
show
sign
cellmedi
lesion
howev
experiment
control
rat
group
inflammatori
infiltr
tissu
histopatholog
sign
acut
chronic
inflamm
detect
liver
four
bn
rat
inject
hgcl
g
bodi
wt
everi
day
total
three
inject
total
amount
g
bodi
wt
control
four
bn
rat
inject
h
follow
schedul
anim
sacrif
day
treatment
b
cell
obtain
six
cervic
lymph
node
mercurytr
control
lung
mercurytr
control
lung
lesion
characterist
interstiti
pneumon
compris
polymorphonuclear
neutrophil
leukocyt
eosinophil
leukocyt
andor
mononuclear
cell
also
examin
thyroid
group
addit
rat
inject
total
dose
g
bodi
wt
respect
chronic
inflamm
present
thyroid
bn
rat
inject
hgcl
watertr
control
pancrea
peripancreat
tissu
mercurytr
control
anim
also
show
chronic
inflamm
exposur
mercuri
may
result
autoimmun
respons
diseas
human
phenomenon
highlight
import
health
risk
environment
chemic
review
effect
investig
experiment
administr
hgcl
rabbit
mice
rat
depend
anim
speci
differ
type
autoimmun
respons
observ
treatment
mercuri
strain
mice
balbc
akr
produc
autoantibodi
react
nuclear
antigen
scarc
absent
renal
immun
deposit
similarli
human
subject
druginduc
lupu
mous
strain
sjlj
produc
high
level
autoantibodi
nucleolar
fibrillarin
rnp
protein
resembl
serolog
find
observ
subset
scleroderma
patient
brown
norway
rat
mercuri
induc
autoantibodi
laminin
renal
igg
deposit
nephrot
syndrom
present
survey
larg
number
bn
rat
inject
hgcl
h
confirm
previou
report
autoimmun
respons
laminin
induc
mercuri
treatment
correl
total
amount
xenobiot
administ
examin
varieti
tissu
stain
dif
igg
deposit
also
valid
earlier
literatur
report
renal
extraren
linear
igg
deposit
previous
describ
literatur
complement
detect
immun
deposit
bound
renal
gbm
inflammatori
chang
glomeruli
shown
tabl
kidney
mercurytr
bn
rat
sacrif
day
linear
immunoglobulin
deposit
gbm
level
present
histopatholog
pattern
membran
nephropathi
ie
noninflammatori
lesion
igg
deposit
linear
distribut
also
present
varieti
tissu
contrari
previou
report
observ
variat
cell
possibl
immunoregulatori
subpopul
correl
kinet
mercuryinduc
autoimmun
respons
demonstr
tabl
signific
chang
percentag
singl
posit
cell
time
similarli
consist
variat
cell
express
ie
doubleposit
lymphocyt
differ
data
obtain
cervic
lymph
node
report
author
use
mesenter
lymph
node
may
due
sourc
lymphocyt
test
fcm
surfac
marker
cell
may
chang
mesenter
lymph
node
cervic
lymph
node
variat
caus
migrat
pattern
integrin
local
cytokin
product
go
possibl
favor
observ
standard
mercuri
treatment
caus
gener
hyperplasia
spleen
lymph
node
suggest
equal
involv
lymphoid
site
without
evid
region
effect
howev
issu
solv
detail
compar
analysi
fcm
chang
differ
lymph
node
perform
futur
investig
cell
great
interest
mason
group
suggest
high
lymphocyt
might
low
lymphocyt
howev
cell
contain
tcell
popul
experi
data
shown
observ
major
actual
b
cell
conclus
fcm
data
suggest
cell
may
import
regulatori
role
mercuryinduc
autoimmun
bn
rat
still
unclear
whether
role
exercis
lymphocyt
subpopul
previous
shown
cell
decreas
mercuri
treatment
bn
rat
find
confirm
present
studi
tabl
lymphocyt
one
variou
put
immunoregulatori
subpopul
shown
tabl
also
notic
earli
increas
nk
nk
lymphocyt
time
day
circul
autoantibodi
laminin
detect
rat
test
may
intrigu
find
deserv
addit
investig
view
recent
interest
modulatori
function
nk
cell
graftversushostlik
gvhl
syndrom
describ
bn
rat
inject
mercuri
syndrom
character
widespread
necrot
leukocytoclast
vascul
bowel
skin
pancrea
liver
lung
varieti
organ
public
specifi
hgcl
treat
bn
rat
develop
sever
inflamm
ulcer
skin
perior
skin
footpad
day
treatment
microscop
examin
area
reveal
ulcer
surfac
epithelium
underli
mononuclear
cell
inflamm
subepiderm
perihair
follicl
lymphocyt
infiltr
addit
mercurytr
bn
rat
develop
vascul
bowel
biphas
pattern
first
phase
earli
vascul
start
day
initi
treatment
ie
two
inject
second
phase
late
vascul
character
sever
tissu
injuri
occur
day
five
six
inject
duodenum
show
promin
foci
intens
leucocyt
infiltr
lamina
propria
serosa
colon
sever
necrot
vascul
submucos
vessel
moder
sever
mononuclear
cell
infiltr
close
vessel
liver
contain
portal
collect
larg
activ
lymphocyt
pancrea
peripancreat
mononuclear
cell
infiltr
occasion
heterophil
leukocyt
also
report
lung
one
control
anim
mercurytr
rat
mild
interstiti
pneumon
character
heterophil
leukocyt
lymphocyt
infiltr
find
interpret
confirm
old
hypothesi
xenobioticinduc
autoimmun
respons
resembl
graftversushost
reaction
experi
agre
observ
care
examin
paraffinembed
h
estain
well
plasticembed
toluidinebluestain
thin
section
tissu
larg
number
mercurytr
control
bn
rat
tabl
detect
histopatholog
alter
skin
intestin
anim
gross
examin
tissu
also
shown
lesion
thu
two
primari
target
organ
cellmedi
immun
damag
graftvshost
diseas
found
complet
normal
hand
acut
andor
chronic
inflamm
present
tissu
control
experiment
rat
thyroid
control
mercurytr
bn
rat
show
area
chronic
inflamm
visibl
differ
two
group
anim
pancrea
similarli
affect
experiment
control
sign
acut
chronic
inflamm
detect
frequent
liver
control
rat
mercurytr
anim
lung
control
mercuryinject
bn
rat
particularli
involv
acut
chronic
inflammatori
process
suggest
subclin
microbi
infect
occur
respiratori
tract
organ
anim
differ
result
describ
previous
author
difficult
explain
great
major
bn
rat
receiv
mercuri
subcutan
standard
dose
ident
use
report
describ
gvhl
patholog
exclud
possibl
variat
due
dosag
rout
administr
mercuri
hand
might
strain
differ
bn
rat
use
report
exhibit
gvhl
lesion
possibl
suggest
chang
incid
autoimmun
respons
diseas
sublin
inbr
rat
mice
howev
one
public
mathieson
group
state
similar
gvhl
find
obtain
bn
rat
two
differ
commerci
sourc
establish
coloni
thu
cast
doubt
strain
differ
hypothesi
opinion
like
explan
may
provid
report
show
inflammatori
chang
variou
tissu
disappear
antibiot
treatment
thu
possibl
inflamm
result
consequ
synergist
effect
mercuri
microorgan
rat
specificpathogenfre
occasion
outbreak
infect
occur
experiment
anim
even
obtain
reliabl
supplier
despit
best
precautionari
measur
infect
possibl
aggrav
immunotox
effect
mercuri
andor
stress
anesthesia
repeat
inject
mercuri
distil
water
may
respons
diffus
inflammatori
reaction
appear
induct
gvhl
syndrom
possibl
confirm
find
acut
chronic
inflammatori
chang
lung
control
well
mercurytr
rat
conclus
studi
show
autoimmun
respons
induc
administr
mercuri
bn
rat
associ
inflammatori
chang
skin
intestin
seem
result
xenobioticinduc
gvhl
effect
surpris
mercuri
caus
autoimmun
direct
stimul
varieti
lymphocyt
subpopul
involv
induct
effector
phase
immun
respons
also
inhibit
immunoregulatori
cell
effect
resembl
activ
infecti
microorgan
anoth
possibl
caus
autoimmun
diseas
may
mediat
interact
pattern
recognit
receptor
molecul
present
cell
immun
system
also
caus
reaction
cellular
protein
thiol
modif
host
tissu
epitop
well
induct
cell
death
apoptosi
andor
necrosi
summari
numer
divers
mechan
like
result
autoimmun
induc
mercuri
therefor
investig
immun
cell
molecular
pathway
involv
autoimmun
effect
metal
consider
interest
deeper
understand
xenobioticinduc
idiopath
autoimmun
diseas
